• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Fundraising

Personal contributions: keeping skin in the game

Personal contributions aid fundraising and deal execution
  • Alice Murray
  • Alice Murray
  • 13 August 2015
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Private equity’s cherished alignment is falling away as GP contributions continue to dwindle. Thankfully, a handful of funds are continuing to keep the model on track by committing meaningful amounts to vehicles. Alice Murray reports

In July, Elysian Capital reached a final close for its second fund on £250m after just five months on the road. While the rapid raise could well be explained by the performance of Elysian's first vehicle coupled with continued strong demand for UK funds, according to the firm's founder Ken Terry, there was another important reasoning at play; namely, the GP's substantial personal commitments to both of its funds.

Terry's story and the foundation of Elysian is a compelling one. Terry was previously a founding partner at Doughty Hanson but interestingly left the GP in the mid-00s to do a history degree. "As a mature student you have much more free time, and I used that to invest in a few funds myself as an LP," says Terry. However, he soon realised that a better idea would be to invest in himself.

Terry set up Elysian in 2007, to do just that, and began fundraising in 2008; an undeniably challenging time for a first-time fund to go out on the road. "But as we wanted to invest in ourselves, LPs were really open to the idea, which was crucial to that fundraise," says Terry. Indeed, Elysian was the only first-time fund to raise in 2009.

While Terry established the firm on the basis of wanting to invest in himself, during the early stages he was not aware of the powerful message this would carry. It was only after meeting with a US endowment who explained how desperate they were to see meaningful GP contributions that made Terry aware of how unique his fund was.

Terry soon realised that Elysian's personal contribution was creating a good reputation for the firm; it was sending out a clear message that this GP is truly committed to alignment.

Buy-side bonus
While Elysian's beginnings benefited from Terry's philosophy in terms of raising capital, another surprise came when the GP began speaking to management teams. "I didn't realise the importance on the buy-side," he says. "We have won competitive deals against funds that only have 1% commitments. This is because our personal contribution shows that we will fight for our portfolio companies. If there is no personal commitment there is a possibility that fund managers might switch off when times get tough. For us this isn't a possibility; we really want to fight for every investment.

"Entrepreneurs and management teams, who are naturally suspicious of private equity, like the fact that we are investing personally alongside them, as partners rather than just as owners."

Indeed, the ability to create an immediate bond with an entrepreneur or business owner through the common ground of having committed a huge amount to each enterprise, goes beyond giving the GP offering a differentiated approach – it shouts: we are the same.

As Terry rightly points out, the lower-mid-market in which Elysian operates is all about relationships. And for Elysian, the key has been to build those relationships through true partnership. To be able to say; if you fail, I fail too.

Because the "personal" factor is less prevalent in the mid and upper markets, where leaders of companies are far less likely to be the founder, one could argue that achieving strong alignment through personal contributions to the fund is less needed. However, taking this view may create negative feelings among LPs as it would highlight the manager as less concerned by its overall performance – what does it matter if it is someone else's money that is lost?

Unfortunately, however, this kind of thinking is present throughout the industry. At a recent industry event, the topic of GP contributions was raised and one manager labelled it a "non-issue".

Conservative approach
Elysian's performance over the last eight years highlights the hugely positive impact GP contributions have on fundraising and on winning deals. However, some LPs have raised concerns that a heavy personal contribution could lead to a more conservative approach to deal-doing. "I don't think this is the case," says Terry. "While I was at university the second time, I did some personal investments in 2005-2006 and effectively overpaid for them. When investing other people's money, I think I have always used a much higher standard of care and concern regardless of my personal commitment."

Following a second successful fundraise, Elysian now counts an 11% personal contribution across both of its funds; a far cry from the industry standard of 1-2%. Of course, looking at GP contributions in terms of percentages is not a fair way of assessing how meaningful a personal contribution is, as larger funds would require much bigger cheques. For example, an 11% contribution to a £500m fund would require a £55m commitment, which for a small team, especially one that may only be on its second or third vehicle so does not have the benefit of large carry cheques coming out of previous funds, would understandably be a struggle.

And despite Elysian's relatively smaller fund size – its first vehicle raising £130m and its second £250m – Terry agrees that the focus should not be on percentages. "The GP commitment is now 11% across both funds, with more in the first and less in the second because it is difficult to keep that pace up as the fund size increases. But it's not about the percentage, it's about the message."

Furthermore, GP contributions are not reserved to the partners themselves in order to squirrel away the resulting carry cheques. For Elysian, it is the entire workforce who invests in the fund and benefits from the pay-outs. "This approach is humbling," admits Terry. "With all members of the team investing it shows great faith in what you are doing. Internally, it's a hugely positive thing."

Down to Earth
Fortunately, Terry is not alone in championing personal contributions. One firm operating in the heart of the mid-market, Terra Firma, has been vocal on this issue. Speaking to unquote" back in February, Terra Firma's chief investment officer and chairperson Guy Hands asserted that certain groups of LPs are demanding more meaningful alignment. "Endowments and sovereign wealth funds want something different, something special, and personal contributions from the GP's decision-makers."

For those suspicious of Hands' motives – it is no secret that he has amassed substantial wealth through private equity investing, nor that the GP decided to not raise another institutional fund – sceptics will likely dismiss his view on this as simply a way to entice new investors.

But Elysian and Terra Firma are not alone. Endless is an outstanding example of a fund not only subscribing to this philosophy, but clearly proving its merits. For its Endless Fund IV, the Endless team represented the largest single investor in the newly raised vehicle. What is more, this fund took just two months to raise.

After sweeping through unquote" data to check upon recent fundraising efforts, it appears so far this year only one other fund has detailed its GP contribution – Czech GP Genesis Capital's latest fund, which recently launched, will receive a 2.4% commitment from the partners. The only other GP to comment on personal contributions was PAI following the close of its PAI Europe VI fund – it said a GP contribution was included but declined to comment on just how much.

While raising capital in current market conditions has improved greatly, as LPs pile into funds following two years of record distributions, the deal-doing environment has only become more challenging. And as competition for deals continues to heat up, those GPs that can offer target companies a true partnership will undoubtedly be the ones that win out.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Fundraising
  • Investments
  • Buyouts
  • Buyout
  • GP Contributions
  • Elysian Capital
  • Endless
  • Terra Firma
  • Top story
  • unq2015sep

More on Fundraising

EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Chris Hitchen of Possible Ventures
VC Profile: Possible Ventures lines up frontier tech deals halfway through fresh EUR 60m fundraise

Germany-based pre-seed investor is set to hold a first close for its third fund in mid-September

  • GPs
  • 25 August 2023
Direct lending funds
Hayfin exceeds EUR 6bn target for fourth direct lending fund

Firm expects to raise EUR 7bn by year-end as it gears up to meet growing private credit demand in Europe

  • Fundraising
  • 18 August 2023
Paris's Arc de Triomphe
Eurazeo co-CEOs seek to reassure market following key departures

Listed GP is also considering options for its stake in Spanish PE platform MCH, it said in its latest results

  • GPs
  • 28 July 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013